GlassScriptPhysician profile
Heather A Kostoff
NPI 1568615318
$10,216.53
in general payments reported to CMS, 2019-2025
46 companies · $2,049 in 2025
The $2,049 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,904 · 2022: $2,006 · 2023: $2,045 · 2024: $2,213 · 2025: $2,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,273 · Education: $33.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,272.97 |
| Education | $33.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,539.22 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,843.66 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Nevro Corp. | $909.77 | 2022-2024 | Senza |
| Abbvie INC. | $745.56 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $449.63 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Esperion Therapeutics, INC. | $404.24 | 2021-2024 | Nexletol |
| Amgen INC. | $307.36 | 2021-2025 | Krystexxa, Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $239.42 | 2023-2025 | |
| Dexcom, INC. | $212.71 | 2023-2025 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $198.41 | 2021-2022 | |
| Shield Therapeutics INC | $160.43 | 2023-2025 | Accrufer |
| Mylan Specialty L.P. | $137.60 | 2022-2024 | Yupelri |
| Glaxosmithkline, LLC. | $136.39 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.27 | 2021-2024 | Jardiance, Tradjenta |
| Kowa Pharmaceuticals America, INC. | $133.83 | 2021-2025 | Livalo, Seglentis, Zoryve |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Kostoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.